Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma
剂量调整后的 EPOCH 方案联合利妥昔单抗可改善患有双表达弥漫性大 B 细胞淋巴瘤的年轻患者的临床结局
期刊:Leukemia
影响因子:13.4
doi:10.1038/s41375-018-0320-9
Dodero, A; Guidetti, A; Tucci, A; Barretta, F; Novo, M; Devizzi, L; Re, A; Passi, A; Pellegrinelli, A; Pruneri, G; Miceli, R; Testi, A; Pennisi, M; Di Chio, M C; Matteucci, P; Carniti, C; Facchetti, F; Rossi, G; Corradini, P